Cytokine inter-relationships and their association with disease activity in arthritis

Rheumatology

Volumn 31, Issue 11, 1992, Pages 725-733

  Holt, I ^a   Cooper, R G ^a   Denton, J ^a   Meager, A ^a,b   Hopkins, S J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Bioassay; Immunoassay; Interferon; Interleukins; Leukocytes; Synovial fluid; Tumour necrosis factor

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; ARTICLE; BIOASSAY; BLOOD LEVEL; COMPARATIVE STUDY; DISEASE ACTIVITY; HUMAN; IMMUNOASSAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ARTHRITIS; CYTOKINES; HUMAN; IMMUNOASSAY; LEUKOCYTE COUNT; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-6; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T;

EID: 0026498267     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/31.11.725     Document Type: Article

References (54)

1. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
2. Brennan FM, Field M, Chu CQ, Feldmann M, Maini RN. Cytokine expression in rheumatoid arthritis. Br J Rheumatol 1991;30(Suppl. 1), 76-80.
3. Hopkins SJ. Cytokines and their significance in rheumatic disease. In: Orme M, ed. International encyclopaedia of pharmacology and therapeutics, 133: Anti-rheumatic drugs. New York: Pergamon Press, 1990;49-118.
4. Holt I, Cooper RG, Hopkins SJ. Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. EurJ Clin Invest 1991;21:479-84.
5. Ritchie DM, Boyle JA, Mclnnes JM Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393-406.
6. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diag 1977;18:481-91.
7. Department of Rheumatology and Medical Illustration, University of Manchester, Manchester Royal Infirmary and the Empire Campaign for Chronic Rheumatism. The epidemiology of chronic rheumatism: atlas of standard radiographs, Vol. 2. Philadelphia: F.A. Davis Co., 1963.
8. Hopkins SJ, Humphreys M. Bioassay of interleukin-1 in serum and plasma following removal of inhibitory activity with polyethylene glycol. J Immunol Methods 1990;133:127-31.
9. Hopkins SJ, Humphreys M. Simple, sensitive and specific bioassay of interleukin-1. J Immunol Methods 1989;120:271-6.
10. Helle M, Boeije L, Aarden LA. Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 1988;18:1535-40.
11. Brakenhoff JP, de Groot ER, Evers RF, Pannekock H, Aarden LA. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol 1987;139:4116-21.
12. Hopkins SJ, Meager A. Cytokines in synovial fluid. II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 1988;73:88-92.
13. Grassi J, Roberge CJ, Frobert Y, Pradelles P, Poubelle PE. Determination of IL-la, IL-ip and IL-2 in biological media using specific enzyme immuno- metric assays. Immunol Rev 1991; 119:125-43.
14. Bhardwaj N, Lau LL, Rivelis M, Steinman RM. Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions. Cell Immunol 1988;114:405-23.
15. Hopkins SJ, Humphreys M, Jayson MIV. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 1988;72:422-7.
16. Smith JB, Bocchieri MH, Sherbin-Allen L, Borofsky M, Abruzzi JL. Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and the presence of bioassay-inhibiting factors. Rheumatol Int 1989;9:53-8.
17. Maury CPJ, Andersson LC, Teppo A-M, Partanen S, Juvonen E. Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin ip concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoie- sis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann Rheum Dis 1988;47: 972-8.
18. Symons JA, McDowell TL, Di Giovine FS, Wood NC, Capper SJ, Duff GW. Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint. Lymphokine Res 1989;8:365-72.
19. Di Giovine FS, Poole S, Situnayake RD, Wadhwa M, Duff GW. Absence of correlations between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases. Rheumatol Int 1990;9:259-64.
20. Rooney M, Symons JA, Duff GW. Interleukin-l-beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 1990;10:217-9.
21. Westacott CI, Whicher I, Barnes IC, Thompson D, Swan AJ, Dieppe PA. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 1990;49:676-81.
22. Wahl SM, Allen JB, Wong HL, Dougherty SF, Ellingsworth LR. Antagonistic and agonistic effects of transforming growth factor-f! in rheumatoid synovium. J Immunol 1990;145:2514-9.
23. Eastgate JA, Symons JA, Wood NG, Grinlinton FM, Di Giovine FS, Duff GW. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988;11:706-9.
24. Eastgate JA, Symons JA, Wood NC, Capper SJ, Duff GW. Plasma levels of interleukin-l-alpha in rheumatoid arthritis. Br J Rheumatol 1991;30:295-7.
25. Newton RC, Uhl J, Covington M, Back O. The distribution and clearance of radiolabeled human interleukin-1 beta in mice. Lymphokine Res 1988;7:207-16.
26. Saez-Llorens X, Mustafa MM, Ramilo Oetal. Tumor necrosis factor a and interleukin ip in synovial fluid of infants and children with suppurative arthritis. Am J Dis Child 1990;144:353-6.
27. Miyasaka N, Sato K, Goto M Augmented inter leukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: possible involvement in joint destruction. Arthritis Rheum 1988;31:480-6.
28. Buchan G, Barrett K, Turner M, Chantry S, Maini RN, Feldmann M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-la. Clin Exp Immunol 1988;73:449-55.
29. Saxne T, Palladino MA, Heinegaard D, Talal N, Wollheim FA. Detection of tumor necrosis factor- alpha but not tumor necrosis factor-beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
30. Yocum DE, Esparza L, Dubry S, Benjamin JB, Volz R, Scuderi P. Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell Immunol 1989;122:131-45.
31. Di Giovine FS, Nuki G, Duff GW. Tumour necrosis factor in synovial exudates. Ann Rheum Dis 1988;47:768-72.
32. Di Giovine FS, Meager A, Leung H, Duff GW. Immunoreactive tumour necrosis factor alpha and biological inhibitor(s) in synovial fluids from rheumatic patients. Int J Immunopathol Pharmacol 1988;1:17-26.
33. Neal ML, Williams BD, Matthews N. Tumour nec rosis factor activity in joint fluids from rheumatoid arthritis patients. Br J Rheumatol 1989;28:104-8.
34. Tetta C, Camussi G, Modena V, Di Vittorio C, Baglioni C. Tumor necrosis factor in serum and synovial fluids of patients with active and severe rheumatoid arthritis. Ann Rheum Dis 1990;49:665-7.
35. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 1985;135:3972-7.
36. Blick M, Sherwin SA, Rosenblum M, Gutterman J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987;47:2986-9.
37. Firestein GS, Zvaifler NJ. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that y-interferon is not the primary macrophage activating factor. Arthritis Rheum 1987;30:864-71.
38. Firestein GS, Xu W-D, Townsend K Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and the presence of macrophage colony- stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 1988;168:1573-86.
39. Van Snick J. Interleukin-6: an overview. Ann Rev Immunol 1990;8:253-78.
40. Hirano T, Matsuda T, Turner M Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988; 18:1797-801.
41. Houssiau FA, Devogelaer JP, Van Damme J, Dedeuxchaisnes CN. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31:784-8.
42. Swaak AJ, Van Rooye A, Niewenhuis E, Aarden LA. Interleukin-6 (1L-6) in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol 1988;17:469-74.
43. Honda M, Kitamura K, Mizutani Y Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. J Immunol 1990;145:4059-64.
44. Noma T, Mizuta T, Rosen A, HiranoT, Kishimoto T, Honjo T. Enhancement of the interleukin 2 receptor expression on T cells by multiple B lympho- tropic lymphokines. Immunol Lett 1987;15:249-53.
45. Tsunetsu-Yokata Y, Honda M. Effect of cytokines on HIV release and IL-2 receptor alpha expression in monocyte cell lines. J Acquir Immune Defic Syndr 1990;3:511-6.
46. Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DK, Rubin LA. Elevated soluble interleukin-2 receptor levels in sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 1988;31:844-9.
47. Symons JA, Wood NC, Di Giovine FS, Duff GW. Soluble IL-2 receptor in rheumatoid arthritis. J Immunol 1988;141:2612-8.
48. Semenzato G, Bambara LM, Biasi D Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Invest 1988;8:447-52.
49. Miossec P, Elhamiani M, Edmondsalt X, Sany J, Him M. Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid. Arthritis Rheum 1990;33:1688-94.
50. Endres S, Cannon JG, Ghorbani R In vitro production of IL-ip, IL-la, TNF and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent regulation. Eur J Immunol 1989;19:2327-33.
51. Zvaifler NJ. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 1973;16:316.
52. Kinsella TD. Transformation of human lymphocytes in vitro by autologous and allogenic rheumatoid synovial fluids. Ann Rheum Dis 1976;35:8-13.
53. Davis MJ, Denton J, Freemont AJ, Holt PJL. Comparison of serial synovial fluid cytology in rheumatoid arthritis: delineation of subgroups with prognostic implications. Ann Rheum Dis 1988;47:559-62.
54. Firestein GS, Alvaro-Cracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.